143 related articles for article (PubMed ID: 6203662)
1. Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.
Perez DJ; Powles TJ; Gazet JC; Ford HT; Coombes RC
Cancer Chemother Pharmacol; 1984; 13(1):36-8. PubMed ID: 6203662
[TBL] [Abstract][Full Text] [Related]
2. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Smith IE; Powles TJ
Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
[TBL] [Abstract][Full Text] [Related]
3. A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
Jodrell DI; Smith IE; Mansi JL; Pearson MC; Walsh G; Ashley S; Sinnett HD; McKinna JA
Br J Cancer; 1991 May; 63(5):794-8. PubMed ID: 2039705
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
Rausa L; Russo A; Gebbia V; Gebbia N; D'Alessandro N; Palmeri S
J Cancer Res Clin Oncol; 1991; 117(3):266-8. PubMed ID: 1709643
[TBL] [Abstract][Full Text] [Related]
5. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.
Colozza M; Tonato M; Grignani F; Davis S
Cancer; 1988 Jul; 62(2):262-5. PubMed ID: 3383126
[TBL] [Abstract][Full Text] [Related]
6. Adriamycin (doxorubicin), vinblastine, and mitomycin C combination chemotherapy in refractory breast carcinoma.
Luikart SD; Witman GB; Portlock CS
Cancer; 1984 Oct; 54(7):1252-5. PubMed ID: 6467151
[TBL] [Abstract][Full Text] [Related]
7. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
Andersson M; Daugaard S; von der Maase H; Mouridsen HT
Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, methotrexate,5-fluorouracil, alternating with adriamycin and mitomycin C in metastatic breast cancer: a pilot study.
Cruciani G; Tienghi A; Molinari AL; Fiorentini G; Rosti G; Turci D; Marangolo M
Tumori; 1987 Jun; 73(3):303-7. PubMed ID: 3111046
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin: its evolving role in the treatment of breast cancer.
Hortobagyi GN
Oncology; 1993 Apr; 50 Suppl 1():1-8. PubMed ID: 8483556
[TBL] [Abstract][Full Text] [Related]
12. Vindesine and mitomycin C in chemotherapy: refractory advanced breast cancer.
Di Costanzo F; Gori S; Tonato M; Buzzi F; Crino L; Grignani F; Davis S
Cancer; 1986 Mar; 57(5):904-7. PubMed ID: 3002594
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.
Pronzato P; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso R
Anticancer Res; 1990; 10(6):1743-5. PubMed ID: 2126683
[TBL] [Abstract][Full Text] [Related]
14. Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia.
Panasci L; Shenouda G; Begin L; Pollak M; Reinke A; Margolese R
Cancer Chemother Pharmacol; 1990; 26(6):457-60. PubMed ID: 2121379
[TBL] [Abstract][Full Text] [Related]
15. First-line and salvage therapy of metastatic breast cancer with mitomycin/vinblastine.
Sedlacek SM
Oncology; 1993 Apr; 50 Suppl 1():16-21. PubMed ID: 8483557
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C and vinblastine in the treatment of advanced breast cancer.
Radford JA; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1475-7. PubMed ID: 3938396
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancer.
O'Brien ME; Bayliss EJ; Stewart ME; Smyth JF; Rodger A; Leonard RC
Cancer Chemother Pharmacol; 1990; 27(1):79-80. PubMed ID: 2123134
[TBL] [Abstract][Full Text] [Related]
18. Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy.
Pasterz RB; Buzdar AU; Hortobagyi GN; Blumenschein GR
Cancer; 1985 Nov; 56(10):2381-4. PubMed ID: 4042070
[TBL] [Abstract][Full Text] [Related]
19. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
[TBL] [Abstract][Full Text] [Related]
20. Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.
Sulkes A; Gez E; Pfeffer MR; Catane R; Isacson R; Biran S
Cancer Chemother Pharmacol; 1986; 18(2):162-7. PubMed ID: 3791561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
